Home › Funds › Royce & Associates › SPRO
Royce & Associates position in SPRO
SPERO THERAPEUTICS INC COM · Health Care
Latest position (Q2 2023)22.85K sh
Reported value held$33.13K
Portfolio Weight0.00%
First reportedQ2 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2023 | 22.85K | $33.13K | New |
Other funds holding SPRO
- GSK plc 9.19M sh · $20.31M · Q2 2026
- PFIZER INC 2.36M sh · $5.34M · Q2 2026
- Vanguard Group 2.08M sh · $4.85M · Q4 2025
- VANGUARD CAPITAL MANAGEMENT LLC 2.04M sh · $4.50M · Q2 2026
- Renaissance Technologies 947.90K sh · $2.09M · Q2 2026
- Alphabet Inc. 889.98K sh · $1.97M · Q2 2026
- BlackRock Inc 594.40K sh · $1.31M · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 566.33K sh · $1.25M · Q2 2026
- Geode Capital Management 566.33K sh · $1.25M · Q2 2026
- RAYMOND JAMES FINANCIAL INC 521.71K sh · $1.15M · Q2 2026
- Two Sigma Investments 382.81K sh · $846.02K · Q2 2026
- Arrowstreet Capital 332.97K sh · $735.86K · Q2 2026